Latest filing published 04 Jun 2025 for Dermapharm Holding SE, €100k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Dr. Hans-Georg Feldmeier in Dermapharm Holding SE, where the filings describe the role as senior executive. We count 2 filings, every one of them for a trade on 2 June 2025.
Every open-market trade on record is a purchase: 2 purchases worth €199k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 4 June 2025, the filings show an open-market purchase worth €100k in Dermapharm Holding SE. These figures are compiled from regulatory filings published by BaFin. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations